Tarveda Therapeutics

Last update: October 1, 2020

United States (USA) Its 10 main executives

Recent executive movements at Tarveda Therapeutics

Drew Fromkin, President, Chief Executive Officer and Chairman, has left the company  (news posted on October 1 2020).
Brian Roberts, who was Chief Financial Officer, is promoted to President and Chief Executive Officer  (news posted on October 1 2020).

Create an alert
to follow the executive moves at Tarveda Therapeutics.

Most searched biographies at Tarveda Therapeutics

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Sunesis Pharmaceuticals has announced the acquisition of Viracta Therapeutics (posted on Nov 30, 2020).
Novo Nordisk has announced the acquisition of Emisphere Technologies (posted on Nov 10, 2020).
Sanofi has acquired Kiadis Pharma (posted on Nov 3, 2020).

Other contacts in the Biotechnology industry

Learn more about the Biotechnology industry >

Latest news about Tarveda Therapeutics

Tarveda Therapeutics on Wikipedia, Google News & Yahoo Finance

Tarveda Therapeutics on LinkedIn, Twitter & YouTube

Tarveda Therapeutics has 1,507 competitors including Agilyx (United States (USA)), Biogen (United States (USA)) and Eurofins (France).

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.